Evaxion A-S

Evaxion A‑S insider stake: How Marianne Soegaard’s 3.4 million shares and warrants influence capital strategy, growth prospects, and investor sentiment.

Insider Staal’s steady hold of 129,139 shares and new warrants signals confidence in Evaxion A‑S’s rare‑disease pipeline, hinting at future liquidity, partnerships, and a bullish outlook for investors.

CEO’s steady 2.29 M share holding & monthly warrant vesting shows confidence in Evaxion’s AI‑driven vaccine pipeline, hinting at future upside.

Evaxion A‑S insiders hold 36,765 shares and long‑term warrants, signalling confidence in its AI‑driven vaccine pipeline and potential price rally after key clinical milestones.

CEO‑held shares, warrant vesting, and insider momentum signal strong confidence in Evaxion A‑S’s oncology pipeline and upcoming partnership prospects.